JOURNAL BROWSE
Search
Advanced SearchSearch Tips
Determination of the type-2 diabetes risk status of the individuals who applied to the internal diseases outpatient clinic
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
  • Journal title : TANG [HUMANITAS MEDICINE]
  • Volume 4, Issue 3,  2014, pp.21.1-21.5
  • Publisher : Association of Humanitas Medicine
  • DOI : 10.5667/tang.2014.0016
 Title & Authors
Determination of the type-2 diabetes risk status of the individuals who applied to the internal diseases outpatient clinic
Emine, Kiyak; Nermin, Olgun; Cigdem, Inan;
  PDF(new window)
 Abstract
The purpose of this study is to determine the type-2 diabetes risk status of the individuals applying to the internal diseases outpatient clinic and the affecting factors. This descriptive study was conducted on 500 individuals who applied to the internal diseases department of a hospital in Ordu Turkey, between May and June 2010 without diabetes diagnosis. The questionnaire form and Type 2 Diabetes Risk Assessment Form are used to collect the data. For the evaluation of data; independent samples t-test and One-Way Anova are used to evaluate the data. It is determined that the type-2 diabetes risk an score of the individuals participating in the study is and 32.4% of them have low type-2 diabetes risk score, 26.6% have slightly elevated score, 18% have moderate score, 16.6% have high and 6.4% have very high type-2 diabetes risk score. It is found that the type-2 diabetes risk mean score of the women participating in the study who are adults, are married, have low education level, are unemployed, are non-smoker, do not drink alcohol and do not have any information about type-2 diabetes is statistically significantly high (p < 0.05). It is determined that 16.6% of the individuals participating in the study have high type-2 diabetes risk and 6.4% have very high type-2 diabetes risk.
 Keywords
type-2 diabetes;risk status;
 Language
English
 Cited by
 References
1.
Agardh E, Allebeck P, Hallqvist J, Moradi T, Sidorchuk A. Type 2 diabetes incidence and socio-economic position: a systematic review and meta-analysis. Int J Epidemiol. 2011;40:804-818. crossref(new window)

2.
Alberti KG, Zimmet P, Shaw J. International Diabetes Federation: a consensus on Type 2 diabetes prevention. Diabet Med. 2007;24:451-463. crossref(new window)

3.
Anderson JE, Greene MA, Griffin JW, Kohrman DB, Lorber D, Saudek CD, Schatz D, Siminerio L. Diabetes and employment. Diabetes Care. 2012;35:94-98. crossref(new window)

4.
Borkosky SL, Roukis TS. Incidence of re-amputation following partial first ray amputation associated with diabetes mellitus and peripheral sensory neuropathy: a systematic review. Diabet Foot Ankle. 2012;3:12169.

5.
Cobble ME, Frederich R. Saxagliptin for the treatment of type 2 diabetes mellitus: assessing cardiovascular data. Cardiovasc Diabetol. 2012;11:6. crossref(new window)

6.
Garduno-Diaz SD, Khokhar S. Prevalence, risk factors and complications associated with type 2 diabetes in migrant South Asians. Diabetes Metab Res Rev. 2012;28:6-24. crossref(new window)

7.
Gong Z, Muzumdar RH. Pancreatic function, type 2 diabetes, and metabolism in aging. Int J Endocrinol. 2012;2012:1-13.

8.
Grundy SM. Pre-diabetes, metabolic syndrome, and cardiovascular risk. J Am Coll Cardiol. 2012;59:635-643. crossref(new window)

9.
Guler S, Keskinkilic B, Yardim N, Imamecioglu R, Soylu M, Sarioglu G, Cobanoglu N. Action plan. Turkish diabetes-prevention and control program action plan (2011-2014). (Ankara, Turkey: Republic of Turkey Ministry of Health, General Directorate of Primary Health Care), 2011.

10.
Gunasekaran U, Gannon M. Type 2 diabetes and the aging pancreatic beta cell. Aging. 2011;3:565-575.

11.
Hu FB. Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care. 2011;34:1249-1257. crossref(new window)

12.
Imbeault P, Haman F, Blais JM, Pal S, Seabert T, Krummel EM, Robidoux MA. Obesity and type-2 diabetes prevalence in adults from two remote first nations communities in northwestern ontario, Canada. J Obes. 2011;2011:267509.

13.
Kodama K, Horikoshi M, Toda K, Yamada S, Hara K, Irie J, Sirota M, Morgan AA, Chen R, Ohtsu H, Maeda S, Kadowaki T, Butte AJ. Expression-based genome-wide association study links the receptor CD44 in adipose tissue with type 2 diabetes. Proc Natl Acad Sci USA. 2012;109:7049-7054. crossref(new window)

14.
Mayor S. International Diabetes Federation consensus on prevention of type 2 diabetes. Int J Clin Pract. 2007;61:1773-1775. crossref(new window)

15.
Onat A, Hergenc G, Uyarel H, Can G, Ozhan H. Prevalence, incidence, predictors and outcome of type 2 diabetes in Turkey. Anadolu Kardiyol Derg. 2006;6:314-321.

16.
Onat A, Ozhan H, Esen AM, Albayrak S, Karabulut A, Can G, Hergenc G. Prospective epidemiologic evidence of a "protective" effect of smoking on metabolic syndrome and diabetes among Turkish women-without associated overall health benefit. Atherosclerosis. 2007;193:380-388. crossref(new window)

17.
Onat A. Dynamics in cardiometabolic risk among Turkish adults: Similarities to that in Iranians? Int J Prev Med. 2011;2:56-63.

18.
Robbins JM, Vaccarino V, Zhang H, Kasl SV. Socioeconomic status and diagnosed diabetes incidence. Diabetes Res Clin Pract. 2005;68:230-236. crossref(new window)

19.
Sacerdote C, Ricceri F, Rolandsson O, Baldi I, Chirlaque MD, Feskens E, Bendinelli B, Ardanaz E, Arriola L, Balkau B, Bergmann M, Beulens JW, Boeing H, Clavel-Chapelon F, Crowe F, de Lauzon-Guillain B, Forouhi N, Franks PW, Gallo V, Gonzalez C, Halkjaer J, Illner AK, Kaaks R, Key T, Khaw KT, Navarro C, Nilsson PM, Dal Ton SO, Overvad K, Pala V, Palli D, Panico S, Polidoro S, Quiros JR, Romieu I, Sanchez MJ, Slimani N, Sluijs I, Spijkerman A, Teucher B, Tjonneland A, Tumino R, van der A D, Vergnaud AC, Wennberg P, Sharp S, Langenberg C, Riboli E, Vineis P, Wareham N. Lower educational level is a predictor of incident type 2 diabetes in European countries: the EPIC-InterAct study. Int J Epidemiol. 2012;41:1162-1173. crossref(new window)

20.
Salopuro TM, Saaristo T, Oksa H, Puolijoki H, Vanhala M, Ebeling T, Niskanen L, Tuomilehto J, Uusitupa M, Peltonen M. Population-level effects of the national diabetes prevention programme (FIN-D2D) on the body weight, the waist circumference, and the prevalence of obesity. BMC Public Health. 2011;11:350. crossref(new window)

21.
Satman I, Imamoglu S, Yilmaz C. Diagnosis treatment and follow up guideline for diabetes mellitus and its complications. 6th ed. (Ankara, Turkey: The Society of Endocrinology and Metabolism of Turkey), 2009.

22.
Shi L, van Meijgaard J, Fielding J. Forecasting diabetes prevalence in California: a microsimulation. Prev Chronic Dis. 2011;8:A80.

23.
Thomas MC, Groop PH, Tryggvason K. Towards understanding the inherited susceptibility for nephropathy in diabetes. Curr Opin Nephrol Hypertens. 2012;21:195-202. crossref(new window)

24.
Waugh N, Scotland G, McNamee P, Gillett P, Brennan A, Goyder E, Williams R, John A. Screening for type 2 diabetes: literature review and economic modelling. Health Technol Assess. 2007;11:1-125.

25.
Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2007;298:2654-2664. crossref(new window)

26.
Wu SF, Liang SY, Wang TJ, Chen MH, Jian YM, Cheng KC. A self-management intervention to improve quality of life and psychosocial impact for people with type 2 diabetes. J Clin Nurs. 2011;20:2655-2665. crossref(new window)

27.
Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, Chen SJ, Dekker JM, Fletcher A, Grauslund J, Haffner S, Hamman RF, Ikram MK, Kayama T, Klein BE, Klein R, Krishnaiah S, Mayurasakorn K, O'Hare JP, Orchard TJ, Porta M, Rema M, Roy MS, Sharma T, Shaw J, Taylor H, Tielsch JM, Varma R, Wang JJ, Wang N, West S, Xu L, Yasuda M, Zhang X, Mitchell P, Wong TY. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35:556-564. crossref(new window)